NFSG
CRVO icon

Newbridge Financial Services Group’s CervoMed CRVO Stock Holding History

Newbridge Financial Services Group’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.3K Hold
3,000
– – ﹤0.01% 860
2026
Q1 		$11.8K Hold
3,000
– – ﹤0.01% 765
2025
Q4 		$23.7K Buy
+3,000
New +$24.1K ﹤0.01% 597

Other funds holding CRVO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

Newbridge Financial Services Group's CRVO Position: Q2 2026 in Review

Newbridge Financial Services Group held its CervoMed (CRVO) position steady in Q2 2026 at 3,000 shares worth $9.3K. The position accounts for ﹤0.01% of the portfolio, ranked #860.

Newbridge Financial Services Group first reported a position in CRVO in Q4 2025 and has held it in 3 quarters since. The position peaked at $23.7K in Q4 2025. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Newbridge Financial Services Group held 3,000 shares of CervoMed worth $9.3K as of Q2 2026.
  • Newbridge Financial Services Group left its CervoMed share count unchanged in Q2 2026.
  • CervoMed made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #860 holding.
  • Newbridge Financial Services Group first reported a position in CervoMed in Q4 2025 and has held it in 3 quarters since.
  • Newbridge Financial Services Group's CervoMed position peaked at $23.7K in Q4 2025.
  • 37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.